Abstract 18040: Activated Factor X Signaling Pathway via Protease-Activated Receptor-2 is a Novel Therapeutic Target to Prevent Atrial Fibrillation

Takeshi Soeki(Tokushima University), Masataka Sata(Tokushima University), Tomomi Matsuura(Keio University), Kenya Kusunose(University of the Ryukyus), Takayuki Ise(Tokushima University Hospital), Daiju Fukuda(Osaka Metropolitan University), Koji Yamaguchi(University of Occupational and Environmental Health Japan), Shusuke Yagi(Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers), Tomoya Hara(Tokushima University), Hirotsugu Yamada(Tokushima University Hospital), Etsuko Uematsu(Tokushima University), Tetsuzo Wakatsuki(Tokushima University), Takeshi Tobiume(Tokushima University)

Circulation

November 14, 2017

Cited by 0

|Cell stem cell|2012|1.1k

|Journal of the American College of Cardiology|2017|271

|Cell Metabolism|2016|252

|Nature Communications|2014|250

|Circulation Research|2009|211

Related Papers